New combo aims to stall advanced breast cancer
NCT ID NCT07441486
First seen Mar 03, 2026 · Last updated May 15, 2026 · Updated 12 times
Summary
This study tests a combination of two drugs, entinostat and oral paclitaxel, in people with a certain type of advanced breast cancer (HR+HER2-). The goal is to see if this treatment can slow down the cancer's growth. About 50 adults who have already tried 2 to 4 other treatments will take part. The study is not yet recruiting.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.